The anti-CD133 antibodyies are Fc-modified chimeric monoclonal antibodies specifically binding to CD133, which is a cholesterol-binding transmembrane glycoprotein and expressed on the cell surface of somatic stem cell. With the enhanced ADCC, the specific antibodies can be used for the treatment of CD133-related diseases such as chronic lymphocytic leukemia and myelodysplastic syndrome.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.